Sai et al. [78] compared genetic variants in three candidate genes (SLCO1B1, RYR2, and GATM) and four HLA genes in 52 patients who had experienced statin-induced myopathies and 2878 healthy controls. The gene discussed is GATM; the disease is myopathy.